SGMTSagimet Biosciences Inc.
$8.91+21% 1Y
$8.91
$4.5552 weeks$11.16
SGMT as reported
- Net income
- −$47M
Net income · −21% year on year · trailing twelve months to Q2 2026
- EPS
- −$1.29
EPS · −30% year on year · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net income | −$47M | −21% | Q2 2026 |
| EPS | −$1.29 | −30% | Q2 2026 |
| ROE | −39% | n/a | Q2 2026 |
| ROA | −37% | n/a | Q2 2026 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Sagimet Biosciences Inc. (SGMT) · Net incomeNet incomeSagimet Biosciences Inc. (SGMT)